Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05879887 · ClinicalTrials.gov registry record · NA
An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure
A NA study of Chronic Illness and Heart Failure - NYHA II - IV, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05879887: Active NA study of Chronic Illness and Heart Failure - NYHA II - IV, sponsored by University of Alabama at Birmingham.
NCT05879887 is a NA study of Chronic Illness and Heart Failure - NYHA II - IV that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 64 participants, below the 583-participant average among 5 other Chronic Illness trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05879887, a NA study of Chronic Illness and Heart Failure - NYHA II - IV, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial pilot trial is to identify feasibility, acceptability, and preliminary efficacy of components of an intervention (UPHOLDS) to improve quality of life of older adults with advancing heart failure. Using a 2x2x2x2 factorial design, 64 adults with advancing heart failure will be randomized to receive one or more palliative care coach-delivered components, based on Ferrans' Health-Related Quality of Life Model: 1) psychoeducation on palliative care principles (4 vs. 8 sessions); 2) financial coaching (yes vs. no); 3) one-time specialty outpatient palliative care consultation (yes vs. no); and monthly follow (1 monthly follow-up call vs. monthly follow-up calls for 24 weeks).
Primary Outcome
Proportion of participants who complete assigned intervention components and study-related assessments.
Conditions Studied
Interventions
- BEHAVIORAL UPHOLDS (Utilizing Palliative Care for Heart Failure Optimized using Lay Navigators to Decrease Suffering)
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-08-15 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What the registry record for NCT05879887 still lists
NCT05879887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 583-participant average among 5 other Chronic Illness trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Chronic Illness appearing as the primary indexed condition, and to 1 intervention - of which UPHOLDS (Utilizing Palliative Care for Heart Failure Optimized using Lay Navigators to Decrease Suffering) is the first listed.
NCT05879887 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05879887 about?
NCT05879887 is a clinical study titled "An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure". Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial pilot trial is to identify feasibility, acceptability, and preliminary efficacy of components of an intervention (UPHOLDS) to improve quality of life of older adults with adva...
What is the current status of trial NCT05879887?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-08-15. Estimated completion is 2026-07-30.
What conditions does trial NCT05879887 study?
This clinical trial studies the following conditions: Chronic Illness, Heart Failure - NYHA II - IV.
What interventions are being tested in trial NCT05879887?
The interventions under investigation include: UPHOLDS (Utilizing Palliative Care for Heart Failure Optimized using Lay Navigators to Decrease Suffering) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05879887?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05879887 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
RECRUITING · NA
-
Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)
ACTIVE NOT RECRUITING · NA
-
Comprehensive Care of Children With Medical Complexity
COMPLETED · NA
-
Virtually-integrated Co-management Between Complex Care and Community-based Primary Care Providers
COMPLETED · NA
-
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI